Personalized Breast Care

Increase invasive cancer detection in dense breasts with Invenia™ ABUS 2.0

An innovative ultrasound specifically designed for supplemental screening, diagnosis, staging, and monitoring cancer in dense breast tissue.

Designed for supplemental screening, diagnostics, and beyond

ABUS helps to find small cancers in dense breasts for early treatment

Expand access

Multi-layer technology and remote reading foster equitable, patient-centered care

Extraordinary patient comfort

100% of women¹ would recommend non-invasive ABUS to their best friend

Operational efficiency

Grow your ABUS program while maximizing resource utilization

CARE FOR DENSE BREASTS

Personalized breast care with Invenia ABUS 2.0 for early cancer detection and confident early diagnosis.

Transform your breast care screening program from reactive to proactive. Invenia ABUS 2.0 helps to detect breast cancers in challenging dense tissue.

THE DENSE BREAST CHALLENGE

How can you find invasive cancers in dense breast tissue?

Invenia ABUS is a great tool. It's the first FDA-approved ultrasound supplemental screening that is specifically designed for detecting cancer successfully in dense breast tissue.
Clinical research studies have demonstrated that when used an adjunct to mammography, cancers visible only through ABUS were predominantly invasive and node-negative.^2,3 Detecting them at this early stage has important prognostic implications and may help reduce the cost of care.⁴ In addition, the ABUS Viewer's innovative open platform design for AI tools helps clinicians streamline reading and gain clinical confidence.

CLINICALLY-FOCUSED

How can ABUS help maximize your resources as you help patients along along the stages of the breast care pathway?

Invenia ABUS shows the benefits of remote reading. With its multilayer imaging technology that views the coronal plane plus powerful AI support, ABUS may help you enhance your diagnostic confidence and your patient throughput.

PATIENT-FOCUSED

How can you make the screening process comfortable for your patients?

ABUS is perceived to be significantly less painful than digital screening mammography, regardless of breast size.¹ ABUS is a non-invasive test, without X-ray exposure and without the need for an intra-venous contrast injection. For comfort, the exam is conducted in a supine position and women can request different compression levels.

ACCESSIBILITY-FOCUSED

How can you deliver personalized safe screening for women with dense breasts – everywhere?

The new Mobile Invenia ABUS 2.0 allows you to bring extraordinary patient care to more places. Deliver care via a dedicated mobile screening coach or transport your ABUS system to multiple facilities via truck or van using the Mobile ABUS Fixation Bracket*. Expand your reach and protect your investment as you grow your ABUS program. For women with dense breasts. Everywhere.

REFERENCES

1. Shah et.al. Journal of Diagnostic Medical Sonography DOI: 10.1177/8756479313476920 2013.
2. FDA PMA P110006 summary of safety and effectiveness.
3. Wilczek B, European Journal of Radiology (DOI: 10.1016/j.ejrad.2016.06.004).
4. Blumen, et al. Comparison of treatment costs for breast cancer by tumor stage, and type of service.

*The Invenia ABUS 2.0 device is not designed for use in a mobile environment unless it is installed using the Mobile ABUS fixation system.

JB21620XX